KEVIN MYIRSKI: Open Payments
NPI 1982190112 · FORT HOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 31 payments from 12 companies in 2025. Trend: 2023 $82 · 2024 $1,496 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $224 |
| LivaNova USA, Inc. | 1 | $117 |
| Janssen Pharmaceuticals, Inc | 3 | $103 |
| Teva Pharmaceuticals USA, Inc. | 3 | $102 |
| E.R. Squibb & Sons, L.L.C. | 2 | $55 |
| Alkermes, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Corium, LLC | 1 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
Products named: VRAYLAR, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, SPRAVATO, AUSTEDO XR, COBENFY, LYBALVI, REXULTI, CAPLYTA.
Industry payments across TX — which companies pay providers there.
